CSAM Health Group AS
CSAM Health Group AS (CSAMF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for CSAM Health Group AS (CSAMF), covering cash flow, earnings, and balance sheets.
CSAM Health Group AS (CSAMF) Income Statement & Financial Overview
Analyze CSAM Health Group AS’s CSAMF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $115.36M | $9.53M | $104.17M | $105.24M |
| Cost of Revenue | $9.06M | $6.75M | $7.70M | $7.53M |
| Gross Profit | $106.30M | $2.78M | $96.47M | $97.71M |
| Gross Profit Ratio | $0.92 | $0.29 | $0.93 | $0.93 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | -$542024.00 | $0.00 | $0.00 |
| Operating Expenses | $113.74M | -$542024.00 | $96.47M | $97.71M |
| Total Costs & Expenses | $122.80M | $6.20M | $104.17M | $105.24M |
| Interest Income | -$6.98M | $0.00 | -$6.27M | $312000.00 |
| Interest Expense | $14.90M | $0.00 | $15.14M | $14.82M |
| Depreciation & Amortization | $12.88M | $1.40M | $14.43M | $14.02M |
| EBITDA | -$1.53M | $2.09M | $4.17M | $15.32M |
| EBITDA Ratio | -$0.01 | $0.22 | $0.04 | $0.15 |
| Operating Income | -$7.44M | $3.32M | -$3.99M | $994000.00 |
| Operating Income Ratio | -$0.06 | $0.35 | -$0.04 | $0.009 |
| Other Income/Expenses (Net) | -$21.88M | -$2.55M | -$21.41M | -$14.51M |
| Income Before Tax | -$29.32M | $773796.00 | -$25.41M | -$13.52M |
| Income Before Tax Ratio | -$0.25 | $0.08 | -$0.24 | -$0.13 |
| Income Tax Expense | $2.95M | $157981.00 | -$1.79M | -$282000.00 |
| Net Income | -$32.27M | $931777.00 | -$23.62M | -$13.24M |
| Net Income Ratio | -$0.28 | $0.10 | -$0.23 | -$0.13 |
| EPS | -$1.60 | $0.05 | -$1.16 | -$0.65 |
| Diluted EPS | -$1.60 | $0.05 | -$1.16 | -$0.65 |
| Weighted Avg Shares Outstanding | $20.18M | $20.18M | $20.31M | $20.42M |
| Weighted Avg Shares Outstanding (Diluted) | $20.18M | $20.18M | $20.31M | $20.42M |
Over the last four quarters, CSAM Health Group AS's revenue moved from $105.24M in Q1 2024 to $115.36M in Q4 2024. Operating income in Q4 2024 was -$7.44M, with a strong operating margin of -6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for CSAM Health Group AS remained robust at -$1.53M, reflecting operational efficiency. Net income dropped to -$32.27M, with an EPS of -$1.60. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan